1. Home
  2. STXS vs BWAY Comparison

STXS vs BWAY Comparison

Compare STXS & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.19

Market Cap

139.3M

Sector

Health Care

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$12.63

Market Cap

547.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STXS
BWAY
Founded
1990
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
547.7M
IPO Year
2004
2011

Fundamental Metrics

Financial Performance
Metric
STXS
BWAY
Price
$1.19
$12.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$3.00
★ $19.27
AVG Volume (30 Days)
★ 449.0K
77.2K
Earning Date
08-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
N/A
★ N/A
Revenue
★ $29,346,617.00
N/A
Revenue This Year
$6.04
$32.42
Revenue Next Year
$33.01
$23.40
P/E Ratio
★ N/A
$81.98
Revenue Growth
N/A
★ N/A
52 Week Low
$1.22
$11.77
52 Week High
$3.59
$26.63

Technical Indicators

Market Signals
Indicator
STXS
BWAY
Relative Strength Index (RSI) 37.01 31.45
Support Level N/A $11.90
Resistance Level $1.98 $14.83
Average True Range (ATR) 0.06 0.55
MACD -0.01 -0.02
Stochastic Oscillator 9.39 0.61

Price Performance

Historical Comparison
STXS
BWAY

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: